Home > Request Information
Title:
Tessa Therapeutics to Host Scientific Session on CD30 CAR-T Targeting of CD30+ Lymphomas at the SDCT-REMEDIS Cell Therapy Conference 2022
* Company:
* Country:
* Name:
Job Title:
* Tel:
Fax:
* E-mail:
Message:
Verification Code:
refresh